Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement
This continuing medical education activity is provided by 
Support Statement
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Target Audience
The intended audience for this activity is infectious disease specialists, internists, pharmacists, and other health care professionals involved in the management of patients with human immunodeficiency virus.
Learning Objective
Upon successful completion of this educational activity, participants should be better able to examine the potential use of long-acting injectable antiretroviral therapy (ART) formulations in patients with HIV who struggle with stigma and/or adherence to prescribed regimens.
Activity Chair
Richard A. Elion, MD
Director of Clinical Research
Washington Health Institute
Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC
Faculty
Chloe Orkin, MBBCh, FRCP
Consultant Physician Barts Health NHS Trust
Clinical Lead for COVID 19 Research at Barts Health NHS Trust
Lead for HIV and HIV/Hep C Research
Athena Swan Chair, Queen Mary University of London School of Medicine
London, United Kingdom
Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is acceptable for 0.25 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-20-018-H02-P, effective 11/30/2020. This is a knowledge-based activity and there is no fee to attend.
This enduring material is approved for 1 year from the date of original release, November 30, 2020, through November 29, 2021.
How to Participate in This Activity and Obtain CME Credit
To participate in this CE activity, you must read the objective, answer the pretest questions, listen to the podcast, and complete the CE posttest and evaluation. Provide only one (1) correct answer for the question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate or an ACPE Statement of Credit. Vindico will report pharmacist learners to CPE monitor within 30 days of completion of the activity.
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s and Accreditation Council for Pharmacy Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control.
Activity Chair and Faculty report the following relationship(s)
Richard A. Elion, MD
Speakers Bureau: Gilead, ViiV
Contracted Research (paid to institution): Gilead, Merck, ViiV
Scientific Advisory Board: Gilead, ViiV
Chloe Orkin, MBBCh, FRCP
Speakers Bureau: Gilead, GlaxoSmithKline, Merck, ViiV
Contracted Research: Gilead, GlaxoSmithKline, Merck, ViiV
Reviewers report the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP
Contracted Research (Paid to Institution): ViiV
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the Podcast title and can be emailed to CME@VindicoCME.com. Requests will be honored within 3-5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com